Bda Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 M
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.99 Cr
- Revenue Growth -21.90%
- Profit Growth -1.23%
- Ebitda 12.56%
- Net Worth 18.90%
- Total Assets 4.64%
About Bda Pharma
Bda Pharma Private Limited (BPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 09 April 2008 and has a history of 16 years and ten months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹1.99 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Santosh Deshpande and Shubhankar Deshpande serve as directors at the Company.
Company Details
-
Location
Nagpur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24239MH2008PTC180992
-
Company No.
180992
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Apr 2008
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Bda Pharma Private Limited offer?
Bda Pharma Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Kidney Drugs, Juices, Soups & Soft Drinks, Fruit Juice, Hair Shampoo, Herbal Shampoo, Pharmaceutical Medicine, Sexual Wellness Products, Female Hygiene Products & Test Kits, Bath Tools.
Who are the key members and board of directors at Bda Pharma?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Santosh Deshpande | Managing Director | 09-Apr-2008 | Current |
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shubhankar Deshpande | Director | 07-Aug-2020 | Current |
Financial Performance of Bda Pharma.
Bda Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.9% decrease. The company also saw a slight decrease in profitability, with a 1.23% decrease in profit. The company's net worth Soared by an impressive increase of 18.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bda Pharma?
In 2023, Bda Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹1.99 Cr
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 1.99 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
27 Sep 2018 | Yes Bank Limited | ₹1.99 Cr | Satisfied |
How Many Employees Work at Bda Pharma?
Bda Pharma has a workforce of 28 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bda Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bda Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.